Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive Review of AL amyloidosis: some practical recommendations.
Al Hamed R, Bazarbachi AH, Bazarbachi A, Malard F, Harousseau JL, Mohty M. Al Hamed R, et al. Among authors: harousseau jl. Blood Cancer J. 2021 May 18;11(5):97. doi: 10.1038/s41408-021-00486-4. Blood Cancer J. 2021. PMID: 34006856 Free PMC article. Review.
Daratumumab in transplant regimens for myeloma?
Harousseau JL, Mohty M. Harousseau JL, et al. Blood. 2020 Aug 20;136(8):917-918. doi: 10.1182/blood.2020006298. Blood. 2020. PMID: 32818244 Free article. No abstract available.
Up-front ixazomib in older patients with myeloma.
Harousseau JL, Mohty M. Harousseau JL, et al. Blood. 2021 Jul 1;137(26):3584-3586. doi: 10.1182/blood.2021011262. Blood. 2021. PMID: 34196682 Free article. No abstract available.
Requirements for operational cure in multiple myeloma.
Mohty M, Avet-Loiseau H, Harousseau JL. Mohty M, et al. Among authors: harousseau jl. Blood. 2021 Oct 21;138(16):1406-1411. doi: 10.1182/blood.2021012854. Blood. 2021. PMID: 34324647 Free article.
Continuous reduced nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a single-institution's three decade experience.
Malard F, Chevallier P, Guillaume T, Delaunay J, Rialland F, Harousseau JL, Moreau P, Mechinaud F, Milpied N, Mohty M. Malard F, et al. Among authors: harousseau jl. Biol Blood Marrow Transplant. 2014 Aug;20(8):1217-23. doi: 10.1016/j.bbmt.2014.04.021. Epub 2014 Apr 23. Biol Blood Marrow Transplant. 2014. PMID: 24769328 Free article.
Relapsed refractory multiple myeloma: a comprehensive overview.
Bazarbachi AH, Al Hamed R, Malard F, Harousseau JL, Mohty M. Bazarbachi AH, et al. Among authors: harousseau jl. Leukemia. 2019 Oct;33(10):2343-2357. doi: 10.1038/s41375-019-0561-2. Epub 2019 Aug 27. Leukemia. 2019. PMID: 31455853 Review.
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.
Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien ML, Dejoie T, Maheo S, Stoppa AM, Pegourie B, Karlin L, Garderet L, Arnulf B, Doyen C, Meuleman N, Royer B, Eveillard JR, Benboubker L, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Kolb B, Fohrer C, Mohty M, Macro M, Richardson PG, Carlton V, Moorhead M, Willis T, Faham M, Anderson KC, Harousseau JL, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H, Munshi N. Perrot A, et al. Among authors: harousseau jl. Blood. 2018 Dec 6;132(23):2456-2464. doi: 10.1182/blood-2018-06-858613. Epub 2018 Sep 24. Blood. 2018. PMID: 30249784 Free PMC article. Clinical Trial.
550 results